William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: TRDA) | Delayed: 4.64 -0.11 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.75 | 52 Week High | $ | |||
| Open | $4.72 | 52 Week Low | $ | |||
| Day High | $4.85 | P/E | N/A | |||
| Day Low | $4.58 | EPS | $ | |||
| Volume | 74,047 | |||||
